Austedo® XR (deutetrabenazine) – New formulation approval
February 17, 2023 - Teva Pharmaceuticals announced the FDA approval of Austedo XR (deutetrabenazine), in adults for the treatment of chorea associated with Huntington’s disease and tardive dyskinesia.
Download PDF
